Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on protonic acid catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN115873002B offers eco-friendly Remdesivir intermediate synthesis. Reduces waste, improves scalability for reliable pharmaceutical intermediate supply chains.
Patent CN103664821B reveals mild protonic acid catalysis for benzothiazole. Offers cost reduction and supply reliability for pharma intermediates.
Novel protonic acid catalysis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel protonic acid catalysis enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable supply chain reliability.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Solve C-H activation challenges in pharmaceutical intermediates with green protonic acid catalysis. 91% yield, no precious metals, and industrial scalability for R&D and procurement teams.
Solve complex tetracyclic indole synthesis challenges with protonic acid catalysis. Achieve 70-97% yields, simplified operations, and cost savings. Partner with NINGBO INNO PHARMCHEM for reliable CDMO solutions.